FDA
-
-
-
-
-
-
-
Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Is Investigating Accelerate Diagnostics, and Instil and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Instil Bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Instil Bio Reports First Quarter 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Instil Bio Presents Subset Analysis of Patients with Checkpoint-Refractory Advanced Melanoma from Compassionate Use Study at 2021 ESMO Congress
-
-
-
-
-
-
-
Instil Bio Reports First Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
251,891 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All